Merck To Grow Group Sales Organically By More Than 6% Annually - Quick Facts

Merck said the company expects Group sales to grow organically by more than 6% annually on average up to 2025. Around 80% of the planned sales growth is to come from the "Big 3" businesses.

Merck is planning to increase its total investments between 2021 and 2025 by more than 50% compared with the period from 2016 to 2020. More than 70% of this is to be invested in the "Big 3". The company still considers targeted smaller to medium-sized acquisitions to be more likely than major transformational deals.

"We will continue to consistently and purposefully invest in areas that make us strong and thus aim to increase our Group sales to approximately 25 billion euros by 2025," said Belén Garijo, CEO of Merck.

Merck increased its medium-term growth forecast for the Life Science business sector. The company now expects average organic sales growth of 7% to 10% per year. Previously, the company had expected medium-term average annual organic sales growth of 6% to 9%.

In the Healthcare business sector, the company expects medium-term average annual organic sales growth in the mid single-digit percentage range.

The Electronics business sector is now planned to grow organically by 3% to 6% per year on average between 2021 and 2025. Previously, growth of between 3% and 4% was expected.

Merck also plans to achieve gender parity in leadership positions by 2030.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT